These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 23146673)

  • 1. A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants.
    Bustamante LY; Bartholdson SJ; Crosnier C; Campos MG; Wanaguru M; Nguon C; Kwiatkowski DP; Wright GJ; Rayner JC
    Vaccine; 2013 Jan; 31(2):373-9. PubMed ID: 23146673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms in malaria vaccine candidate Plasmodium falciparum reticulocyte-binding protein homologue-5 among populations in Lagos, Nigeria.
    Ajibaye O; Osuntoki AA; Balogun EO; Olukosi YA; Iwalokun BA; Oyebola KM; Hikosaka K; Watanabe YI; Ebiloma GU; Kita K; Amambua-Ngwa A
    Malar J; 2020 Jan; 19(1):6. PubMed ID: 31906953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent strain-transcending parasite-neutralizing antibodies.
    Reddy KS; Pandey AK; Singh H; Sahar T; Emmanuel A; Chitnis CE; Chauhan VS; Gaur D
    Infect Immun; 2014 Jan; 82(1):152-64. PubMed ID: 24126527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens.
    Williams AR; Douglas AD; Miura K; Illingworth JJ; Choudhary P; Murungi LM; Furze JM; Diouf A; Miotto O; Crosnier C; Wright GJ; Kwiatkowski DP; Fairhurst RM; Long CA; Draper SJ
    PLoS Pathog; 2012; 8(11):e1002991. PubMed ID: 23144611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APC-Targeted DNA Vaccination Against Reticulocyte-Binding Protein Homolog 5 Induces
    Bjerkan L; Visweswaran GRR; Gudjonsson A; Labbé GM; Quinkert D; Pattinson DJ; Spång HCL; Draper SJ; Bogen B; Braathen R
    Front Immunol; 2021; 12():720550. PubMed ID: 34733274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naturally acquired antibodies specific for Plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malaria.
    Tran TM; Ongoiba A; Coursen J; Crosnier C; Diouf A; Huang CY; Li S; Doumbo S; Doumtabe D; Kone Y; Bathily A; Dia S; Niangaly M; Dara C; Sangala J; Miller LH; Doumbo OK; Kayentao K; Long CA; Miura K; Wright GJ; Traore B; Crompton PD
    J Infect Dis; 2014 Mar; 209(5):789-98. PubMed ID: 24133188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.
    Ntege EH; Arisue N; Ito D; Hasegawa T; Palacpac NMQ; Egwang TG; Horii T; Takashima E; Tsuboi T
    Vaccine; 2016 Nov; 34(46):5612-5622. PubMed ID: 27692771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody.
    Douglas AD; Williams AR; Illingworth JJ; Kamuyu G; Biswas S; Goodman AL; Wyllie DH; Crosnier C; Miura K; Wright GJ; Long CA; Osier FH; Marsh K; Turner AV; Hill AV; Draper SJ
    Nat Commun; 2011 Dec; 2():601. PubMed ID: 22186897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein.
    Ord RL; Caldeira JC; Rodriguez M; Noe A; Chackerian B; Peabody DS; Gutierrez G; Lobo CA
    Malar J; 2014 Aug; 13():326. PubMed ID: 25135070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extent and Dynamics of Polymorphism in the Malaria Vaccine Candidate
    Ouattara A; Tran TM; Doumbo S; Adams M; Agrawal S; Niangaly A; Nelson-Owens S; Doumtabé D; Tolo Y; Ongoiba A; Takala-Harrison S; Traoré B; Silva JC; Crompton PD; Doumbo OK; Plowe CV
    Am J Trop Med Hyg; 2018 Jul; 99(1):43-50. PubMed ID: 29848401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-guided insights into potential function of novel genetic variants in the malaria vaccine candidate PfRh5.
    Mangou K; Moore AJ; Thiam LG; Ba A; Orfanó A; Desamours I; Ndegwa DN; Goodwin J; Guo Y; Sheng Z; Patel SD; Diallo F; Sene SD; Pouye MN; Faye AT; Thiam A; Nunez V; Diagne CT; Sadio BD; Shapiro L; Faye O; Mbengue A; Bei AK
    Sci Rep; 2022 Nov; 12(1):19403. PubMed ID: 36371450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational structure-guided design of a blood stage malaria vaccine immunogen presenting a single epitope from PfRH5.
    Harrison TE; Alam N; Farrell B; Quinkert D; Lias AM; King LDW; Barfod LK; Draper SJ; Campeotto I; Higgins MK
    EMBO Mol Med; 2024 Oct; 16(10):2539-2559. PubMed ID: 39223355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5.
    Douglas AD; Williams AR; Knuepfer E; Illingworth JJ; Furze JM; Crosnier C; Choudhary P; Bustamante LY; Zakutansky SE; Awuah DK; Alanine DG; Theron M; Worth A; Shimkets R; Rayner JC; Holder AA; Wright GJ; Draper SJ
    J Immunol; 2014 Jan; 192(1):245-58. PubMed ID: 24293631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype.
    Barrett JR; Pipini D; Wright ND; Cooper AJR; Gorini G; Quinkert D; Lias AM; Davies H; Rigby CA; Aleshnick M; Williams BG; Bradshaw WJ; Paterson NG; Martinson T; Kirtley P; Picard L; Wiggins CD; Donnellan FR; King LDW; Wang LT; Popplewell JF; Silk SE; de Ruiter Swain J; Skinner K; Kotraiah V; Noe AR; MacGill RS; King CR; Birkett AJ; Soisson LA; Minassian AM; Lauffenburger DA; Miura K; Long CA; Wilder BK; Koekemoer L; Tan J; Nielsen CM; McHugh K; Draper SJ
    Cell; 2024 Sep; 187(18):4964-4980.e21. PubMed ID: 39059380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a potent combination of key Plasmodium falciparum merozoite antigens that elicit strain-transcending parasite-neutralizing antibodies.
    Pandey AK; Reddy KS; Sahar T; Gupta S; Singh H; Reddy EJ; Asad M; Siddiqui FA; Gupta P; Singh B; More KR; Mohmmed A; Chitnis CE; Chauhan VS; Gaur D
    Infect Immun; 2013 Feb; 81(2):441-51. PubMed ID: 23184525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmodium falciparum merozoite surface antigen, PfRH5, elicits detectable levels of invasion-inhibiting antibodies in humans.
    Patel SD; Ahouidi AD; Bei AK; Dieye TN; Mboup S; Harrison SC; Duraisingh MT
    J Infect Dis; 2013 Nov; 208(10):1679-87. PubMed ID: 23904294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralising antibodies block the function of Rh5/Ripr/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytes.
    Healer J; Wong W; Thompson JK; He W; Birkinshaw RW; Miura K; Long CA; Soroka V; Søgaard TMM; Jørgensen T; de Jongh WA; Weir C; Svahn E; Czabotar PE; Tham WH; Mueller I; Barlow PN; Cowman AF
    Cell Microbiol; 2019 Jul; 21(7):e13030. PubMed ID: 30965383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malaria.
    Reiling L; Richards JS; Fowkes FJ; Wilson DW; Chokejindachai W; Barry AE; Tham WH; Stubbs J; Langer C; Donelson J; Michon P; Tavul L; Crabb BS; Siba PM; Cowman AF; Mueller I; Beeson JG
    PLoS One; 2012; 7(9):e45253. PubMed ID: 23028883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiprotein complex between the GPI-anchored CyRPA with PfRH5 and PfRipr is crucial for Plasmodium falciparum erythrocyte invasion.
    Reddy KS; Amlabu E; Pandey AK; Mitra P; Chauhan VS; Gaur D
    Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1179-84. PubMed ID: 25583518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-step design of a stable variant of the malaria invasion protein RH5 for use as a vaccine immunogen.
    Campeotto I; Goldenzweig A; Davey J; Barfod L; Marshall JM; Silk SE; Wright KE; Draper SJ; Higgins MK; Fleishman SJ
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):998-1002. PubMed ID: 28096331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.